A Bioequivalence Study Of Proposed Bevacizumab Biosimilar Myl-1402O (A) Vs Eu-Avastin (B) And Us-Avastin (C).

Autor: Hummel, Matthew, Bosje, Tjerk, Shaw, Andrew
Zdroj: Journal of Cancer Research & Therapeutics. 2017 Supplement, Vol. 13, pS22-S23. 2p.
Databáze: Academic Search Ultimate